chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Significant  left shoulder pain now for almost 10 months. decreasing in the past couple months. I had never had any problems with my left shoulder previously to having the Moderna vaccination. The left shoulder pain started the evening after first vaccination. Limited range of motion. Increase pain with movement of shoulder.  Second Moderna shot on 2/5/2021 in left shoulder  increased the pain and decreased range of motion even more. Severe pain with movement of shoulder.  Booster on 8/31/2021 in the right shoulder cause very little discomfort.   I had several Osteopathic doctors treat my shoulder with very little to no benefit. This fall I started a new therapy that directly targeted the rotator muscles of the left shoulder and upper arm.  I would say I have about 75 to 80 % improvement. Most of that in the past couple months.
Information has been received from a registered nurse concerning a female with no drug reactions or allergies who on 28-DEC-2007 was vaccinated subcutaneously into the thigh with 0.65ml of Zostavax (Oka/Merck) ( Lot #656394/0162U).  Concomitant therapy included NORVASC, omeprazole, prednisone, PRINIVIL, VYTORIN, TOBRADEX, hydrochlorothiazide, nitroglycerin, xanthophyll, TOPROL XL TABLETS, acetaminophen, calcium (unspecified) and aspirin.  Post vaccination the patient developed localized redness, firmness and discomfort. At the time of reporting the patient had recovered.  Unspecified medical attention was sought.  There was no product quality complaint.  Additional information is not expected.
patient not received the 2nd dose yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (on 2022 received 1st dose.).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: patient not received the 2nd dose yet).  The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt date: 13-OCT-2023 A pharmacist reported that the patient received dose one of Shingrix in 2022 and was now presenting for dose two of the series.  Till the time of reporting the patient had not received the second dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
On June 15, 2021. I had pain in the shoulder, muscles and joints of my shoulders and upper arms, above the elbow.  And pain in the legs from the hips down to my ankles. The pain would come  on during the night and I  would wake up to so much pain that I couldn't get out of bed. It would get better through the morning and by noon it would be significantly better. These are classic symptoms of polymyalgia rheumatica. I went to see 06/28/2021,  Dr. confirmed the diagnosis, polymyalgia rheumatica by blood test. Certain blood test markers, that showed they were very high marker for polymyalgia rheumatica. On this same visit, the doctor noticed that my blood pressure was high, 155/45, and my heartbeat was  between 150-160 beats per minute. He ordered an EKG, and diagnosed me with Atrial flutter. Treatment for polymyalgia: Steroid Prednisone. Treatment for Atrial flutter : beta blocker-metoprolol for the electrical signals to the heart. Eliquis, blood thinner that prevents blood clots.   Prior to the Moderna vaccine I never had pain in my muscles and joints and I never had high blood pressure, and fast heart beat. The recovery for the polymyalgia is a 2 year regimen of taking Prednisone. Atrial flutter and high blood pressure are controlled by medication.
body aches; Fever; Chills; Pain at injection site; This is a spontaneous report from a contactable other healthcare professional. A 35-year-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, batch/lot: EL1284), intramuscular in the right arm on 28Dec2020 17:45 at a single dose for Covid-19 immunisation. The patient's medical history was none. Patient has no known allergies. Concomitant medication included paracetamol (TYLENOL), ibuprofen and multivitamins. On 29Dec2020, the patient experienced fever, chills, pain at injection site, and body aches. They all started the day after the injection and where mostly gone by the day after that. No treatment was given to the patient for the event. The outcome of the event was recovered in Dec2020. Vaccine was administered in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not have COVID prior to vaccination. Patient has not been tested positive for COVID post vaccination.
Dizzy, seeing white, world disappears, feel faint, broke out into sweat, face is ghostly white. Episode lasted about 10 to 15 minutes. Went to bed, slept, This happened at 2pm on February 1. Felt all right after sleeping. Talked with my doctor on Feb. 2 and started taking electrolytes. Have been okay.
After patient had the immunizations TDAP, Hep A, and Menveo, the patient was fine but about a minute later her passed out and was unresponsive for about 10 seconds.
This spontaneous report as received from registered nurse refers to a 62 year old male patient. Patient had elevated cholesterol, impaired fasting glucose. On an unspecified date in past patient experienced muscle pain while using LIPITOR, Fenofibrate, NIASPAN. On 04-MAR-2014 the patient was vaccinated with ZOSTAVAX, (route of administration, dose strength was not reported). Concomitant therapies included LIVALO, meclizine, testosterone undecanoate (manufacturer unknown) and VALIUM. On 05-MAR-2014 (AE onset date also reported as 09-MAR-2014), 2 days after dose administration the patient experienced fatigue (disability), diffuse varicella like rash on the trunk of his body after receiving ZOSTAVAX (disability), fever (disability) and cough (disability). On an unknown date laboratory test conducted was chest x-ray and unspecified blood test with unknown results. Patient sought medical attention. The nurse stated that the patient was unable to work at his job, since 05-MAR-2014 due to these symptoms. The outcome of cough, diffuse varicella like rash on the trunk of his body, fever and fatigue was reported as recovering. The relation between ZOSTAVAX and the event was unknown. Additional information has been requested.
terrible rash / It is spreading and not getting better, it is all over her body, stomach, face.; My eyes started to getting itchy now, this is blinding my eyesight. I can't go to work; itchy and miserable; itchy and miserable; it started on the arm that consumer got the vaccination; This is a spontaneous report from a contactable Consumer (Patient). A 61-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EWO180) via an unspecified route of administration on an unspecified date (61 years age at the time of vaccination) as dose 2, single for COVID-19 immunization. The patient medical history had chemotherapy and radiation (further not clarified) in the past and high blood pressure. The concomitant medications were not reported. The patient previously received the first dose of the covid vaccine, consumer thought that it was a low dose and felt tired. But nothing really traumatic. It was not so bad. Consumer stated that consumer took the second vaccination, probably now, after eight to nine days, consumer have a terrible series of rash throughout my body. Consumer can't think of anything else it would be coming from and it started on the arm that consumer got the vaccination, and it seems to be travelling around my body and it went from my arm to my stomach to the other side. It's terribly itchy. It is on my face. When probed for the date of first shot: The last one was on June 5th I believe. The first one was on 15May. The second one was on 05Jun and the both was on right date. Consumer had chemotherapy and radiation (further not clarified) in the past and high blood pressure. Maybe it was not approved for people with chemotherapy in the past and radiation. I mean this is pretty miserable and consumer don't want to miss work for it. If this is going, my eyes started to getting itchy now, this is blinding my eyesight. Consumer can't go to work. The outcome of the events was unknown.  Follow attempts are needed; Additional information has been requested.
Pt developed fever, cough and production of yellow phlegm for 4-5 days prior to clinic visit.  When Pt was examined and labs draw he was found to have blood and protein in his urine. labs from 5/21 BUN 16 Cr 1.77, 5/25 BUN 17 Cr 2.01. Labs prior to vaccine from 02/2020 wer BUN 15, Cr 1.07
Developed 3 small blood clots in his left lower leg on Saturday, 3/10/2021 - swelling and slight redness along with pain
Chest Pain; Tired; Body aches; Felt weak; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt weak), CHEST PAIN (Chest Pain), FATIGUE (Tired) and MYALGIA (Body aches) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 0441321A) for COVID-19 vaccination.     The patient's past medical history included Sickness (Patient may have had Covid-19 in February 2020 he was very sick at that time. Not diagnosed as Covid-19) in February 2020.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced ASTHENIA (Felt weak), FATIGUE (Tired) and MYALGIA (Body aches). On an unknown date, the patient experienced CHEST PAIN (Chest Pain). At the time of the report, ASTHENIA (Felt weak), FATIGUE (Tired) and MYALGIA (Body aches) outcome was unknown and CHEST PAIN (Chest Pain) had resolved.            No concomitant medications were provided. No treatment medications were taken by the patient.   This case was linked to MOD-2021-406148, MOD-2021-406203 (Patient Link).
Approximately the next day after my 2nd booster (Dose 4) I experienced the following symptoms: Redness and swelling on the neck. I went to the Emergency Room and the doctor assessed that I have an allergic reaction to something but they cannot determine what was it. I was prescribed with prednisone. As of today 04/29/2022 I am still experiencing the same symptoms which have spread out all over my body.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. Pertinent medical history and drug reaction include latex allergy. On 21-FEB-2013 the patient was vaccinated with GARDASIL dose 1. On 22-APR-2013 the patient was vaccinated with GARDASIL dose 2. On 26-AUG-2013 the patient was vaccinated with GARDASIL dose 3. Dose description, concentration and route of administration were not reported. Concomitant medications were not reported. A blood test was performed on an unknown date and the results came back with cancer antigens increased. The outcome of blood cancer antigens increased was reported as not recovered. The relatedness between GARDASIL and cancer antigens increased was not reported. Additional information has been requested.
Information has been received from a female patient of unknown age, referring on herself. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date in April 2018 (reported as "a week ago"), the patient was vaccinated with a dose of M-M-R II (lot number, expiration date, administration route and anatomical location were not reported) for prophylaxis. The patient stated that she was currently nursing her child. The outcome of breast feeding was unknown and the causality between the vaccination with M-M-R II and the event was not reported.
This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered too early) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered too early). On 13-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered too early) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant drugs and treatment medications were reported.This case was linked to US-MODERNATX, INC.-MOD-2021-128426, US-MODERNATX, INC.-MOD-2021-128544, US-MODERNATX, INC.-MOD-2021-138320 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-128426:cross link US-MODERNATX, INC.-MOD-2021-128544:cross link US-MODERNATX, INC.-MOD-2021-138320:Crosslinked case of reporter- Different patient
Pt received vaccine 5/11.  Does not recall events thereafter. Admitted to hospital 5/13 due to altered mental status.  MRI c/w encephalitis, and in rhabdomyolysis for several days with acute kidney injury requiring dialysis.  Treated with high dose solumedrol and IgG and improving.  Still requiring dialysis but hoping for renal recovery.
Shortness of breath/nasal congestion. Albuterol 90MCG puff(s) QID, Prednisone 40 MG every day.
Patient Reported extreme swelling and bruising that began 2 days after vaccine administration.  Patient presented 1 week later with a large Bruise covering his entire Deltoid and Bicep region of his Left arm.  Arm was cool to the touch and their was no significant swelling noted currently.  Patient did state that initially it was quite swollen and warm to the touch a few days prior.
Pt present with purpura on bilat lower extremities approx 2 hrs post PENTACEL injection. We had a CBC performed to check blood count which was normal.
Tender to the touch; Headache; Swollen gland on the right side of the neck; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tender to the touch), HEADACHE (Headache) and LYMPHADENOPATHY (Swollen gland on the right side of the neck) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced HEADACHE (Headache) and LYMPHADENOPATHY (Swollen gland on the right side of the neck). On 07-Apr-2021, the patient experienced TENDERNESS (Tender to the touch). At the time of the report, TENDERNESS (Tender to the touch), HEADACHE (Headache) and LYMPHADENOPATHY (Swollen gland on the right side of the neck) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
19Jan98 Pt recv 1 dose vax. 19Jan98 Pt exp "rash w/welts & water blisters, 2-3 lesions located at inject site, & 20-30 on back".Mild case w/no serious sequelae. 27Jan98 Pt recovered.
developed COVID symptoms with mild flu-like symptoms; developed COVID symptoms with mild flu-like symptoms; developed COVID symptoms with mild flu-like symptoms; This is a spontaneous report received from non-contactable reporter(s) (Physician) from a sales representative. The reporter is the parent.  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY), administration date Nov2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), INFLUENZA LIKE ILLNESS (non-serious) all with onset Jan2022, outcome "recovered" (Jan2022) and all described as "developed COVID symptoms with mild flu-like symptoms".  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the available information and a possible contributory role of the suspect product BNT162B2 to the development of events drug ineffective, covid19 cannot be totally excluded.,Linked Report(s) : US-PFIZER INC-202200056534 same vaccine, similar AE, different patient
Vomiting (up to 8 days later), lethargic, no appetite, dehydration, had to go back to the hospital for hydration. Stopped walking and talking and interacting with us. Stared into space, very droggy, wanted to sleep all the time; started losing weight and got a very distended abdomen, and loss of appetite. This has lasted for almost 3 full months, now.
Patient got pneumonia shot on 9/2/08.  Came in on 9/8/08 complaining of neck, shoulder pain.  Started night of 9/2/08 after shot.
Following exercising, the pt became suddenly confused, felt like he was in a fog, loss of identity. The pt had no recent memory of conversations he had with his daughter or wife. The pt had difficulty writing NP after my name not knowing or questioning to myself if it was right. The pt was able to function and do his job. The symptoms cleared 6-7 hours later with full recall. The pt also complained that his neck hurt.
Body Aches, Headache, soreness at injection site.  Took some 500mg Acetaminophen, plenty of water and rest
Dizziness, Fever, ACHES & PAINS, CHILLS, INJECTION SITE PAIN & SWELLING Narrative:
Initial literature report received on 01 Nov 2010: This patient with a medical history of heart failure participated in a prospective cohort study to evaluate T cell responses as correlates of protection against influenza following vaccination in older adults. The patients were vaccinated with Influenza virus vaccine 2007/2008 (manufacturer unknown, batch number: unknown) during the fall of 2007. The influenza surveillance was initiated at two study sites at the start of the influenza season in Jan 2008. The mean age of the subjects was 74 years (range 60-92). Patients started reporting influenza-like illness (ILI) symptoms. When reported symptoms met the ILI criteria and were within 5 days of onset, a nasal swab for detection of influenza virus was obtained during a home visit or a clinic visit. A laboratory diagnosis of influenza illness was confirmed by the detection of influenza virus in a polymerase chain reaction (PCR) assay of the nasal swabs or a 4-fold or greater rise in the antibody titer after the illness. Subjects that met both clinical and at least one of the laboratory criteria were identified as laboratory-confirmed influenza (LCI). This patient, who had a history of heart failure, had an antibody titer value of 20, 40, 40, and 640 after 0 weeks, 4 weeks, 10 weeks and 20 weeks of vaccination respectfully. The patient had 4-fold increase in titer value and tested positive for seroconversion of B strain. Therefore this patient was considered as an LCI case of Influenza B. The outcome was not reported.
Began to feel slight pain at injection site Friday, 12/18/2020,  evening and was experiencing significant pain when trying to raise left arm above shoulder height.  This sensation subsided by Sunday, 12/20/2020, morning  Began to have a numbing sensation in both cheeks, nose, and throat on Saturday, 12/19/2020, early evening.  The sensation was similar to that feeling of getting Novocaine at the dentist.  There was no facial swelling, no difficulty breathing, no facial drooping, or slurred speech.  Began to feel dizzy  on Saturday, 12/19/2020, evening and this lasted until Sunday, 12/20/2020, morning.  No sensation of nausea or vomiting.  I contacted my Director and Occ Health dept as instructed.  Occ Health felt that these symptoms may be an inflammatory response to the vaccine, I was advised to take Motrin to see if any relief could be obtained.  Minimal numbness noted in mouth and nose on Monday, 12/21/2020.
09/18/22 presents to ED for "respiratory distress". PMHx of "Leigh's syndrome and epilepsy and G-tube dependence"
pt recv vax 23JUL98 11:30 & @ daycare pt very thirsty; approx 8hr p/vax pt screaming mommy, mommy;upper extremities tremulous, head arched back, eyes rolled back;mottled;pt did not want to be touched;hosp;arthralgia, sz, T95-96;leg extend
Headache  dizzy. Fever. No energy. Ache all over. Soreness at injection site. Nausea.
Patent experienced seizure like activity. Unable to follow commands, LOC x2-3 minutes. EMS immediately summoned over. Fire rescue notified, responded. Patient refused transfer to hospital, signed liability waiver with fire rescue and departed
Information has been received from a consumer concerning his friend, a female who was vaccinated with a dose of GARDASIL on an unspecified date. Subsequently the patient tested positive for "herpes virus" test on an unspecified date. At the time of the report, the outcome was unknown. Additional information is not expected.
SWEATS; CHILLS FOR TWO WEEKS; FEVER; This spontaneous report received from a patient via a company representative concerned a 68 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient might had a very mild case of COVID-19 last year and reacted to the shot. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced sweats, chills for two weeks, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, sweats and chills for two weeks was not reported. This report was non-serious. This case, from the same reporter is linked to 20210908733.
always got sick from the shot; Initial information received on 23-Feb-2022 regarding an unsolicited valid Social Media non-serious case was received from a patient.  This case involves an unknown age and unknown gender patient who always got sick from the shot while receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (dose, frequency, lot number, expiry date: not reported) via unknown route in unknown administration site as prophylactic vaccination. Information on batch number was requested.  It was reported that every year that the patient received the vaccine, the patient always got sick from the shot (illness) (event onset date and latency: unknown). The patient reported not taking the flu shot again.  Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the event (always got sick from the shot).  At time of reporting, the outcome was Unknown for the event always got sick from the shot.
Patient's arm was swollen, red and infected next day. Daughter is going to take him to the hospital today.
pt recv vax & it was determined that the pt failed to seroconvert;It was reported that the pt varicella antibody titer was borderline;
2 days after anthrax vaccination to the right deltoid, patient reported 2 episodes of right arm carpal spasms that lasted for several minutes.  Denies any other associated symptoms such as shortness of breath, chest pain, rash, headache or dizziness.  Patient was reassured and precautions given to return if further problems.